LINC00702: A Potential Drug Target and Biomarker (G100652988)

Target Name: LINC00702

NCBI ID: G100652988

LINC00702

Other Name(s): long intergenic non-protein coding RNA 702 | Long intergenic non-protein coding RNA 702

LINC00702: A Potential Drug Target and Biomarker

LINC00702 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. Its full name is long non-coding RNA gene LINC00702, and it is located on chromosome 6p12. LINC00702 has been shown to play a role in the development and progression of various diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases. As a result, it has become a focus of interest in the scientific community and a potential drug target.

The LINC00702 gene is transcribed from a non-coding RNA molecule, which means that it does not contain any coding sequences. Instead, it consists of a series of RNA secondary structures, including intron-exon boundaries, exonic RNA loops, and stem-loop structures. These structures give LINC00702 its unique structure and function.

LINC00702 is expressed in a variety of tissues and organs, including the brain, heart, and kidneys. It is found in the brain, where it is expressed in the prefrontal cortex, hippocampus, and cerebellum. It is also expressed in the heart, where it is found in the myocardium and the atria. Additionally, it is expressed in the kidneys, where it is found in the glomeruli and the interstitial cells.

LINC00702 has been shown to play a role in the development and progression of various diseases. For example, studies have shown that LINC00702 is highly expressed in neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. This suggests that it may be a potential drug target for these diseases. Additionally, LINC00702 has also been shown to be expressed in the blood vessels of individuals with cardiovascular disease, which suggests that it may be a potential biomarker for this disease.

In addition to its potential role in disease, LINC00702 has also been shown to have potential therapeutic applications. For example, studies have shown that LINC00702 can be downregulated by small interfering RNA, which suggests that it may be a potential target for therapeutic intervention. Additionally, LINC00702 has also been shown to interact with various proteins, including the protein heat shock protein (Hsp)70. This suggests that it may be a potential target for drugs that target this protein.

Overall, LINC00702 is a protein that has the potential to be a drug target or biomarker for a variety of diseases. Further research is needed to fully understand its role and potential therapeutic applications.

Protein Name: Long Intergenic Non-protein Coding RNA 702

The "LINC00702 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC00702 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets